Deregulation of the miRNAs expression in cervical cancer: Human papillomavirus implications

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Gómez Gómez, Yazmín ^a,b   Organista Nava, Jorge ^a,b   Gariglio, Patricio ^b  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; DESMOGLEIN 3; MICRORNA; MICRORNA 101; MICRORNA 126; MICRORNA 135B; MICRORNA 141; MICRORNA 146A; MICRORNA 155; MICRORNA 21; MICRORNA 210; MICRORNA 214; MICRORNA 218; MICRORNA 223; MICRORNA 34A; MICRORNA 424; PDZ PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN E6; PROTEIN E7; PROTEIN P53; RAS PROTEIN; RNA; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; TUMOR MARKER;

APOPTOSIS; CANCER CELL CULTURE; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; CARCINOGENESIS; CELL ADHESION; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; DEREGULATION; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; HELA CELL; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MAMMAL CELL; NONHUMAN; ONCOGENE; PROTEIN DEGRADATION; PROTEIN MICROARRAY; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS STRAIN; WART VIRUS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PROGNOSIS; UTERINE CERVIX TUMOR;

FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84893188380     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/407052     Document Type: Review

References (141)

1. Calin G. A., Croce C. M., MicroRNA signatures in human cancers. Nature Reviews Cancer 2006 6 11 857 866 2-s2.0-33750370444 10.1038/nrc1997 (Pubitemid 44629897)
2. Zhang B., Pan X., Cobb G. P., Anderson T. A., MicroRNAs as oncogenes and tumor suppressors. Developmental Biology 2007 302 1 1 12 2-s2.0-33846188098 10.1016/j.ydbio.2006.08.028 (Pubitemid 46096921)
3. Calin G. A., Croce C. M., MicroRNA signatures in human cancers. Nature Reviews Cancer 2006 6 11 857 866 2-s2.0-33750370444 10.1038/nrc1997 (Pubitemid 44629897)
4. Kent O. A., Mendell J. T., A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006 25 46 6188 6196 2-s2.0-33749507943 10.1038/sj.onc.1209913 (Pubitemid 44527849)
5. Miska E. A., How microRNAs control cell division, differentiation and death. Current Opinion in Genetics and Development 2005 15 5 563 568 2-s2.0-24344494340 10.1016/j.gde.2005.08.005 (Pubitemid 41262414)
6. Farazi T. A., Spitzer J. I., Morozov P., Tuschl T., MiRNAs in human cancer. Journal of Pathology 2011 223 2 102 115 2-s2.0-78650034475 10.1002/path.2806
7. Zhang L., Huang J., Yang N., Greshock J., Megraw M. S., Giannakakis A., Liang S., Naylor T. L., Barchetti A., Ward M. R., Yao G., Medina A., Jenkins B. A., Katsaros D., Hatzigeorgiou A., Gimotty P. A., Weber B. L., Coukos G., MicroRNAs exhibit high frequency genomic alterations in human cancer. Proceedings of the National Academy of Sciences of the United States of America 2006 103 24 9136 9141 2-s2.0-33745168962 10.1073/pnas.0508889103 (Pubitemid 43902545)
8. Calin G. A., Sevignani C., Dumitru C. D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C. M., Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America 2004 101 9 2999 3004 2-s2.0-12144290519 10.1073/pnas.0307323101 (Pubitemid 38327724)
9. Calin G. A., Dumitru C. D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., Rassenti L., Kipps T., Negrini M., Bullrich F., Croce C. M., Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America 2002 99 24 15524 15529 2-s2.0-18744396337 10.1073/pnas.242606799 (Pubitemid 35403967)
10. Wilting S. M., Snijders P. J. F., Verlaat W., Jaspers A., van de Wiel M. A., van Wieringen W. N., Meijer G. A., Kenter G. G., Yi Y., le Sage C., Agami R., Meijer C. J. L. M., Steenbergen R. D. M., Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene 2012 2-s2.0-84856778066 10.1038/onc.2012.20
11. Wang X., Tang S., Le S. Y., Lu R., Rader J. S., Meyers C., Zheng Z. M., Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008 3 7 2-s2.0-49749107841 10.1371/journal.pone.0002557 e2557
12. Cai X., Li G., Laimins L. A., Cullen B. R., Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication. Journal of Virology 2006 80 21 10890 10893 2-s2.0-33750305743 10.1128/JVI.01175-06 (Pubitemid 44628938)
13. He L., Thomson J. M., Hemann M. T., Hernando-Monge E., Mu D., Goodson S., Powers S., Cordon-Cardo C., Lowe S. W., Hannon G. J., Hammond S. M., A microRNA polycistron as a potential human oncogene. Nature 2005 435 7043 828 833 2-s2.0-20444467290 10.1038/nature03552 (Pubitemid 40839734)
14. He L., He X., Lim L. P., De Stanchina E., Xuan Z., Liang Y., Xue W., Zender L., Magnus J., Ridzon D., Jackson A. L., Linsley P. S., Chen C., Lowe S. W., Cleary M. A., Hannon G. J., A microRNA component of the p53 tumour suppressor network. Nature 2007 447 7148 1130 1134 2-s2.0-34250851115 10.1038/nature05939 (Pubitemid 47014436)
15. Croce C. M., Oncogenes and cancer. The New England Journal of Medicine 2008 358 5 502 511 2-s2.0-38749114995 10.1056/NEJMra072367 (Pubitemid 351185806)
16. Córdova-Alarcón E., Centeno F., Reyes-Esparza J., García-Carrancá A., Garrido E., Effects of HRAS oncogene on cell cycle progression in a cervical cancer-derived cell line. Archives of Medical Research 2005 36 4 311 316 2-s2.0-20444420843 10.1016/j.arcmed.2005.04.001 (Pubitemid 40798382)
17. Li Y., Wang F., Xu J., Ye F., Shen Y., Zhou J., Lu W., Wan X., Ma D., Xie X., Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. Journal of Pathology 2011 224 4 484 495 2-s2.0-79959975720 10.1002/path.2873
18. Lui W.-O., Pourmand N., Patterson B. K., Fire A., Patterns of known and novel small RNAs in human cervical cancer. Cancer Research 2007 67 13 6031 6043 2-s2.0-34447134869 10.1158/0008-5472.CAN-06-0561 (Pubitemid 47037482)
19. Johnson S. M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K. L., Brown D., Slack F. J., RAS is regulated by the let-7 microRNA family. Cell 2005 120 5 635 647 2-s2.0-20044395613 10.1016/j.cell.2005.01.014 (Pubitemid 40343076)
20. Dufourcq P., Leroux L., Ezan J., Descamps B., Lamazi J. M. D., Costet P., Basoni C., Moreau C., Deutsch U., Couffinhal T., Dupl C., Regulation of endothelial cell cytoskeletal reorganization by a secreted frizzled-related protein-1 and frizzled 4- and frizzled 7-dependent pathway: role in neovessel formation. American Journal of Pathology 2008 172 1 37 49 2-s2.0-38749099461 10.2353/ajpath.2008.070130 (Pubitemid 351186366)
21. Minet E., Michel G., Mottet D., Piret J. P., Barbieux A., Raes M., Michiels C., C-JUN gene induction and AP-1 activity is regulated by a JNK-dependent pathway in hypoxic HepG2 cells. Experimental Cell Research 2001 265 1 114 124 2-s2.0-0035870129 10.1006/excr.2001.5180 (Pubitemid 32989069)
22. Manavi M., Hudelist G., Retter A. F., Gschwandtler D. K., Pischinger K., Czerwenka K., Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma. Gynecologic Oncology 2007 105 2 418 426 2-s2.0-34247098371 10.1016/j.ygyno.2006.12.032 (Pubitemid 46590336)
23. Kottakis F., Polytarchou C., Foltopoulou P., Sanidas I., Kampranis S. C., Tsichlis P. N., FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway. Molecular Cell 2011 43 2 285 298 2-s2.0-79960469058 10.1016/j.molcel.2011.06.020
24. Varambally S., Cao Q., Mani R.-S., Shankar S., Wang X., Ateeq B., Laxman B., Cao X., Jing X., Ramnarayanan K., Brenner J. C., Yu J., Kim J. H., Han B., Tan P., Kumar-Sinha C., Lonigro R. J., Palanisamy N., Maher C. A., Chinnaiyan A. M., Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008 322 5908 1695 1699 2-s2.0-58149239686 10.1126/science.1165395
25. Fang J., Zhang M., Li Q., Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and invasion in cervical cancer. American Journal of the Medical Sciences 2011 342 3 198 204 2-s2.0-80052267968 10.1097/MAJ.0b013e31821335a9
26. Moore H., Gonzalez M., Toy K., Cimino A. M., Argani P., Kleer C., EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis. Breast Cancer Research and Treatment 2013 138 3 741 752 10.1007/s10549-013-2498-x
27. Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., Morey L., Van Eynde A., Bernard D., Vanderwinden J. M., Bollen M., Esteller M., Di Croce L., de Launoit Y., Fuks F., The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006 439 871 874 (Pubitemid 43255707)
28. Holland D., Hoppe K. S., Schuller B., Lohrey C., Maroldt J., Dürst M., Hoppe F. S., Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein. Cancer Research 2008 68 23 9964 9972 2-s2.0-57149107384 10.1158/0008-5472.CAN-08-1134
29. Negrini M., Calin G. A., Breast cancer metastasis: a microRNA story. Breast Cancer Research 2008 10 2, article 303 2-s2.0-48949119481 10.1186/bcr1867
30. Martinez I., Gardiner A. S., Board K. F., Monzon F. A., Edwards R. P., Khan S. A., Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 2008 27 18 2575 2582 2-s2.0-42249105032 10.1038/sj.onc.1210919 (Pubitemid 351550884)
31. Liu B., Peng X. C., Zheng X. L., Wang J., Qin Y. W., MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 2009 66 2 169 175 2-s2.0-66049084202 10.1016/j.lungcan. 2009.01.010
32. Gaffney D. K., Haslam D., Tsodikov A., Hammond E., Seaman J., Holden J., Lee R. J., Zempolich K., Dodson M., Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy. International Journal of Radiation Oncology Biology Physics 2003 56 4 922 928 2-s2.0-0038386695 10.1016/S0360-3016(03)00209-8 (Pubitemid 36794022)
33. Wang X., Tournier C., Regulation of cellular functions by the ERK5 signalling pathway. Cellular Signalling 2006 18 6 753 760 2-s2.0-32144436881 10.1016/j.cellsig.2005.11.003 (Pubitemid 43208930)
34. Li Y., Zhang M., Chen H., Dong Z., Ganapathy V., Thangaraju M., Huang S., Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis. Cancer Research 2010 70 20 7894 7904 2-s2.0-78049308910 10.1158/0008-5472.CAN-10-1675
35. How C., Hui A., Boutros P., Clarke B., Pintilie M., Fyles A., Liu F. F., microRNA-196b regulates HOXB7 in cervical cancer. Cancer Research 2012 72 8, supplement, abstract 2311 1538 7445. Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research, 2012 10.1158/1538-7445.AM2012-2311
36. How C., Hui A. B., Fyles A. W., Liu F. F., The role of microRNA-196b in cervical cancer. Cancer Research 2010 70 8, supplement 1, abstract 2059. Proceedings of the 101st Annual Meeting of the American Association for Cancer Research, 2010 10.1158/1538-7445.AM10-2059
37. Uesugi A., Kozaki K.-I., Tsuruta T., Furuta M., Morita K.-I., Imoto I., Omura K., Inazawa J., The tumor suppressive microRNA miR-218 targets the mTOR component rictor and inhibits AKT phosphorylation in oral cancer. Cancer Research 2011 71 17 5765 5778 2-s2.0-80052218238 10.1158/0008-5472.CAN-11-0368
38. Wu D. W., Cheng Y. W., Wang J., Chen C. Y., Lee H., Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Cancer Research 2010 70 24 10392 10401 2-s2.0-78650409847 10.1158/0008-5472.CAN- 10-2341
39. Tatarano S., Chiyomaru T., Kawakami K., Enokida H., Yoshino H., Hidaka H., Yamasaki T., Kawahara K., Nishiyama K., Seki N., Nakagawa M., miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer. International Journal of Oncology 2011 39 1 13 21 2-s2.0-79956046622 10.3892/ijo.2011.1012
40. Tie J., Pan Y., Zhao L., Wu K., Liu J., Sun S., Guo X., Wang B., Gang Y., Zhang Y., Li Q., Qiao T., Zhao Q., Nie Y., Fan D., MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the robo1 receptor. PLoS Genetics 2010 6 3 2-s2.0-77950428314 10.1371/journal.pgen.1000879 e1000879
41. Legg J. A., Herbert J. M. J., Clissold P., Bicknell R., Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration. Angiogenesis 2008 11 1 13 21 2-s2.0-41049085947 10.1007/s10456-008-9100-x
42. Wang B., Xiao Y., Ding B. B., Zhang N., Yuan X. B., Gui L., Qian K. X., Duan S., Chen Z., Rao Y., Geng J. G., Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell 2003 4 1 19 29 2-s2.0-10744224816 10.1016/S1535-6108(03)00164-8 (Pubitemid 36904158)
43. Gardiner A. S., McBee W. C., Jr., Edwards R. P., Austin M., Lesnock J. L., Bhargava R., Guido R., Khan S. A., MicroRNA analysis in human papillomavirus (HPV)-associated cervical neoplasia and cancer. Journal Carcinogene Mutagene 2011 5 supplement 1, article A55 10.1186/1750-9378-5-S1-A55
44. Yu J., Wang Y., Dong R., Huang X., Ding S., Qiu H., Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion. Journal of Cancer Research and Clinical Oncology 2012 138 4 671 674 2-s2.0-84855474909 10.1007/s00432-012-1147-9
45. Forrest A. R. R., Kanamori M. K., Tomaru Y., Lassmann T., Ninomiya N., Takahashi Y., De Hoon M. J. L., Kubosaki A., Kaiho A., Suzuki M., Yasuda J., Kawai J., Hayashizaki Y., Hume D. A., Suzuki H., Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 2010 24 2 460 466 2-s2.0-76749170274 10.1038/leu.2009.246
46. Pallasch C. P., Patz M., Yoon J. P., Hagist S., Eggle D., Claus R., Debey S. P., Schulz A., Frenzel L. P., Claasen J., Kutsch N., Krause G., Mayr C., Rosenwald A., Plass C., Schultze J. L., Hallek M., Wendtner C.-M., miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood 2009 114 15 3255 3264 2-s2.0-70350452269 10.1182/blood-2009-06-229898
47. Xu J., Li Y., Wang F., Wang X., Cheng B., Ye F., Xie X., Zhou C., Lu W., Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene 2012 2-s2.0-84859083416 10.1038/onc.2012.121
48. Zachos G., Rainey M. D., Gillespie D. A. F., Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects. EMBO Journal 2003 22 3 713 723 2-s2.0-0037415735 10.1093/emboj/cdg060 (Pubitemid 36193615)
49. Volinia S., Calin G. A., Liu C.-G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R. L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C. C., Croce C. M., A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences of the United States of America 2006 103 7 2257 2261 2-s2.0-33144490646 10.1073/pnas.0510565103 (Pubitemid 43271657)
50. Pereira P. M., Marques J. P., Soares A. R., Carreto L., Santos M. A. S., Microrna expression variability in human cervical tissues. PLoS One 2010 5 7 2-s2.0-77955615260 10.1371/journal.pone.0011780 e11780
51. Long M.-J., Wu F.-X., Li P., Liu M., Li X., Tang H., MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells. Cancer Letters 2012 324 186 196 10.1016/j.canlet.2012.05.022
52. Zhang J.-G., Wang J.-J., Zhao F., Liu Q., Jiang K., Yang G. H., MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clinica Chimica Acta International Journal of Clinical Chemistry 2010 411 11-12 846 852 2-s2.0-77956061393
53. Hui A. B. Y., Lenarduzzi M., Krushel T., Waldron L., Pintilie M., Shi W., Perez B. O., Jurisica I., Sullivan B. O., Waldron J., Gullane P., Cummings B., Liu F. F., Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clinical Cancer Research 2010 16 4 1129 1139 2-s2.0-76749160835 10.1158/1078-0432.CCR-09-2166
54. Meng F., Henson R., Wehbe H. J., Ghoshal K., Jacob S. T., Patel T., MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007 133 2 647 658 2-s2.0-34547524771 10.1053/j.gastro.2007.05.022 (Pubitemid 47187346)
55. Zhai Y., Hotary K. B., Nan B., Bosch F. X., Muñoz N., Weiss S. J., Cho K. R., Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Research 2005 65 15 6543 6550 2-s2.0-23044466812 10.1158/0008-5472.CAN-05-0231 (Pubitemid 41060689)
56. Hagemann T., Bozanovic T., Hooper S., Ljubic A., Slettenaar V. I. F., Wilson J. L., Singh N., Gayther S. A., Shepherd J. H., Trappen P. O. A. V., Molecular profiling of cervical cancer progression. British Journal of Cancer 2007 96 2 321 328 2-s2.0-33846474766 10.1038/sj.bjc.6603543 (Pubitemid 46160638)
57. Zhu S., Si M. L., Wu H., Mo Y. Y., MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). Journal of Biological Chemistry 2007 282 19 14328 14336 2-s2.0-34347266556 10.1074/jbc.M611393200 (Pubitemid 47100416)
58. Zhu S., Wu H., Wu F., Nie D., Sheng S., Mo Y. Y., MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Research 2008 18 3 350 359 2-s2.0-40249092910 10.1038/cr.2008.24 (Pubitemid 351333899)
59. Wong Y.-F., Cheung T.-H., Tsao G. S. W., Lo K. W. K., Yim S. F., Wang V. W., Heung M. M. S., Chan S. C. S., Chan L. K. Y., Ho T. W. F., Wong K. W. Y., Li C., Guo Y., Chung T. K. H., Smith D. I., Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. International Journal of Cancer 2006 118 10 2461 2469 2-s2.0-33646448419 10.1002/ijc.21660
60. Yao Q., Xu H., Zhang Q. Q., Zhou H., Qu L. H., MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochemical and Biophysical Research Communications 2009 388 3 539 542 2-s2.0-69549092445 10.1016/j.bbrc.2009.08.044
61. Pan S., Yu F., Gong C., Song E., Tumor invasion and metastasis initiated by mir-106b in breast cancer by targeting BRMS1 and RB. Cancer Research 2009 69 24, supplement. Proceedings of the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, 2009 10.1158/0008-5472.SABCS-09-6157
62. Shai A., Brake T., Somoza C., Lambert P. F., The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Cancer Research 2007 67 4 1626 1635 2-s2.0-33847743738 10.1158/0008-5472.CAN-06-3344 (Pubitemid 46383388)
63. Balsitis S., Dick F., Dyson N., Lambert P. F., Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis. Cancer Research 2006 66 19 9393 9400 2-s2.0-33750369730 10.1158/0008-5472.CAN-06-0984 (Pubitemid 44623635)
64. Araki T., Milbrandt J., Ninjurin2, a novel homophilic adhesion molecule, is expressed in mature sensory and enteric neurons and promotes neurite outgrowth. Journal of Neuroscience 2000 20 1 187 195 2-s2.0-0033995563 (Pubitemid 30220506)
65. Gius D., Funk M. C., Chuang E. Y., Feng S., Huettner P. C., Nguyen L., Bradbury C. M., Mishra M., Gao S., Buttin B. M., Cohn D. E., Powell M. A., Horowitz N. S., Whitcomb B. P., Rader J., Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates. Cancer Research 2007 67 15 7113 7123 2-s2.0-34547637241 10.1158/0008-5472.CAN-07-0260 (Pubitemid 47206538)
66. Wang Y. X., Zhang X. Y., Zhang B. F., Yang C. Q., Chen X. M., Gao H. J., Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. Journal of Digestive Diseases 2010 11 1 50 54 2-s2.0-76349114730 10.1111/j.1751-2980.2009.00413.x
67. Descargues P., Draison C., Bonnart C., Kreft M., Kishibe M., Ishida-Yamamoto A., Elias P., Barrandon Y., Zambruno G., Sonnenberg A., Hovnanian A., Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nature Genetics 2005 37 1 56 65 2-s2.0-19944427605 10.1038/ng1493 (Pubitemid 40070940)
68. Lee J.-W., Park Y.-A., Choi J.-J., Lee Y. Y., Kim C. J., Choi C., Kim T. J., Lee N. W., Kim B. G., Bae D. S., The expression of the miRNA-200 family in endometrial endometrioid carcinoma. Gynecologic Oncology 2011 120 1 56 62 2-s2.0-78649906875 10.1016/j.ygyno.2010.09.022
69. Porkka K. P., Pfeiffer M. J., Waltering K. K., Vessella R. L., Tammela T. L. J., Visakorpi T., MicroRNA expression profiling in prostate cancer. Cancer Research 2007 67 13 6130 6135 2-s2.0-34447132924 10.1158/0008-5472.CAN-07-0533 (Pubitemid 47037493)
70. Iorio M. V., Visone R., Di Leva G., Donati V., Petrocca F., Casalini P., Taccioli C., Volinia S., Liu C.-G., Alder H., Calin G. A., Ménard S., Croce C. M., MicroRNA signatures in human ovarian cancer. Cancer Research 2007 67 18 8699 8707 2-s2.0-34548746977 10.1158/0008-5472.CAN-07-1936 (Pubitemid 47437445)
71. Wang B., Koh P., Winbanks C., Coughlan M. T., McClelland A., Watson A., Jandeleit K. D., Burns W. C., Thomas M. C., Cooper M. E., Kantharidis P., MiR-200a prevents renal fibrogenesis through repression of TGF- β 2 expression. Diabetes 2011 60 1 280 287 2-s2.0-78751516162 10.2337/db10-0892
72. Xu X.-C., Mitchell M. F., Silva E., Jetten A., Lotan R., Decreased expression of retinoic acid receptors, transforming growth factor β involucrin, and cornifin in cervical intraepithelial neoplasia. Clinical Cancer Research 1999 5 6 1503 1508 2-s2.0-0033052303 (Pubitemid 29282959)
73. Budhu A., Ji J., Wang X. W., The clinical potential of microRNAs. Journal of Hematology and Oncology 2010 3, article 37 2-s2.0-77957311397 10.1186/1756-8722-3-37
74. Guo S.-L., Peng Z., Yang X., Fan K. J., Ye H., Li Z. H., Wang Y., Xu X. L., Li J., Wang Y. L., Teng Y., Yang X., mir-148a promoted cell proliferation by targeting p27 in gastric cancer cells. International Journal of Biological Sciences 2011 7 5 567 574 2-s2.0-79960116106
75. De Putte G. V., Holm R., Lie A. K., Tropé C. G., Kristensen G. B., Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis. Gynecologic Oncology 2003 89 1 140 147 2-s2.0-0345701455 10.1016/S0090-8258(03)00010-6 (Pubitemid 36406387)
76. Bernard S., Eilers M., Control of cell proliferation and growth by Myc proteins. Results and Problems in Cell Differentiation 2006 42 329 342 2-s2.0-33748345984 10.1007/400-004 (Pubitemid 44856956)
77. Zhang Z., Sun H., Dai H., Walsh R. M., Imakura M., Schelter J., Burchard J., Dai X., Chang A. N., Diaz R. L., Marszalek J. R., Bartz S. R., Carleton M., Cleary M. A., Linsley P. S., Grandori C., MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 2009 8 17 2756 2768 2-s2.0-69749107748
78. Arvanitis D. A., Spandidos D. A., Deregulation of the G1/S phase transition in cancer and squamous intraepithelial lesions of the uterine cervix: a case control study. Oncology Reports 2008 20 4 751 760 2-s2.0-54949116532 10.3892/or-00000070
79. Yang H., Kong W., He L., Zhao J. J., 'Donnell J. D. O., Wang J., Wenham R. M., Coppola D., Kruk P. A., Nicosia S. V., Cheng J. Q., MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Research 2008 68 425 433 (Pubitemid 351380068)
80. Lee J.-W., Choi C. H., Choi J.-J., Park Y. A., Kim S. J., Hwang S. Y., Kim W. Y., Kim T. J., Lee J. H., Kim B. G., Bae D. S., Altered MicroRNA expression in cervical carcinomas. Clinical Cancer Research 2008 14 9 2535 2542 2-s2.0-52049097315 10.1158/1078-0432.CCR-07-1231
81. Lee J. S., Choi Y. D., Lee J. H., Nam J. H., Choi C., Lee M. C., Park C. S., Kim H. S., Min K. W., Expression of PTEN in the progression of cervical neoplasia and its relation to tumor behavior and angiogenesis in invasive squamous cell carcinoma. Journal of Surgical Oncology 2006 93 3 233 240 2-s2.0-33644906115 10.1002/jso.20493 (Pubitemid 43381997)
82. Ma Y. Y., Wei S. J., Lin Y. C., Lung J. C., Chang T. C., Whang-Peng J., Liu J. M., Yang D. M., Yang W. K., Shen C. Y., PIK3CA as an oncogene in cervical cancer. Oncogene 2000 19 23 2739 2744 2-s2.0-0034713390 (Pubitemid 30339223)
83. Chen C.-Z., Li L., Lodish H. F., Bartel D. P., MicroRNAs modulate hematopoietic lineage differentiation. Science 2004 303 5654 83 86 2-s2.0-0346727524 10.1126/science.1091903 (Pubitemid 38055775)
84. Wan H., Yuan M., Simpson C., Allen K., Gavins F. N. E., Ikram M. S., Basu S., Baksh N., O'Toole E. A., Hart I. R., Stem/progenitor cell-like properties of desmoglein 3dim cells in primary and immortalized keratinocyte lines. Stem Cells 2007 25 5 1286 1297 2-s2.0-34247642647 10.1634/stemcells.2006-0304 (Pubitemid 46684889)
85. Bernards A., Settleman J., Loss of the ras regulator RASAL1: another route to ras activation in colorectal cancer. Gastroenterology 2009 136 1 46 48 2-s2.0-59849100942 10.1053/j.gastro.2008.11.024
86. Zheng Z. M., Baker C. C., Papillomavirus genome structure, expression, and post-transcriptional regulation. Frontiers in Bioscience 2006 11 1 2286 2302 2-s2.0-33744756020 10.2741/1971 (Pubitemid 43822560)
87. Berrington De González A., Green J., Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8, 097 women with squamous cell carcinoma and 1, 374 women with adenocarcinoma from 12 epidemiological studies. International Journal of Cancer 2007 120 885 891 (Pubitemid 46175411)
88. Castellsagué X., Diaz M., de Sanjosé S., Muñoz N., Herrero R., Franceschi S., Peeling R. W., Ashley R., Smith J. S., Snijders P. J. F., Meijer C. J. L. M., Bosch F. X., Plummer M., Moreno V., Alonso de Ruiz P., Chichareon S., Ngelangel C., Eluf-Neto J., Roló A., Caceres E., Santos C., Chaouki N., El Gueddari B., Hammouda D., Rajkumar T., Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. Journal of the National Cancer Institute 2006 98 5 303 315 2-s2.0-33644764973 10.1093/jnci/djj067 (Pubitemid 43338210)
89. Wang X., Wang H. K., Mccoy J. P., Banerjee N. S., Rader J. S., Broker T. R., Meyers C., Chow L. T., Zheng Z. M., Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 2009 15 4 637 647 2-s2.0-62549156668 10.1261/rna.1442309
90. Thorland E. C., Myers S. L., Gostout B. S., Smith D. I., Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 2003 22 8 1225 1237 2-s2.0-0037468256 10.1038/sj.onc.1206170 (Pubitemid 36363386)
91. Yao T., Lin Z., MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20. Biochimica et Biophysica Acta 2012 1822 2 248 260 2-s2.0-83255189410 10.1016/j.bbadis.2011.09.018
92. Nominé Y., Masson M., Charbonnier S., Zanier K., Ristriani T., Deryckère F., Sibler A.-P., Desplancq D., Atkinson R. A., Weiss E., Orfanoudakis G., Kieffer B., Travé G., Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Molecular Cell 2006 21 5 665 678 2-s2.0-33344455029 10.1016/j.molcel.2006.01.024 (Pubitemid 43290733)
93. Au Yeung C. L., Tsang T. Y., Yau P. L., Kwok T. T., Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Oncogene 2011 30 21 2401 2410 2-s2.0-79957611432 10.1038/onc.2010.613
94. Duffy M. J., Maguire T. M., McDermott E. W., 'Higgins N. O., Urokinase plasminogen activator: a prognostic marker in multiple types of cancer. Journal of Surgical Oncology 1999 71 2 130 135 (Pubitemid 29288493)
95. Riethdorf L., Riethdorf S., Petersen S., Bauer M., Herbst H., Jänicke F., Löning T., Urokinase gene expression indicates early invasive growth in squamous cell lesions of the uterine cervix. The Journal of Pathology 1999 189 2 245 250 (Pubitemid 29448920)
96. Chang T.-C., Wentzel E. A., Kent O. A., Ramachandran K., Mullendore M., Lee K., Feldmann G., Yamakuchi M., Ferlito M., Lowenstein C. J., Arking D., Beer M. A., Maitra A., Mendell J. T., Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Molecular Cell 2007 26 5 745 752 2-s2.0-34249817549 10.1016/j.molcel.2007.05.010 (Pubitemid 46856245)
97. Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z., Oren M., Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Molecular Cell 2007 26 5 731 743 2-s2.0-34249822779 10.1016/j.molcel.2007.05.017 (Pubitemid 46856247)
98. Sun F., Fu H., Liu Q., Tie Y., Zhu J., Xing R., Sun Z., Zheng X., Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Letters 2008 582 10 1564 1568 2-s2.0-42049092138 10.1016/j.febslet.2008.03.057
99. Wang X., Meyers C., Guo M., Zheng Z. M., Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway. International Journal of Cancer 2011 129 6 1362 1372 2-s2.0-79960918234 10.1002/ijc.25800
100. Myklebust M. P., Bruland O., Fluge O., Skarstein A., Balteskard L., Dahl O., MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer. British Journal of Cancer 2011 105 11 1719 1725 2-s2.0-81955161860 10.1038/bjc.2011.457
101. Gonzalez S. L., Stremlau M., He X., Basile J. R., Münger K., Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. Journal of Virology 2001 75 16 7583 7591 2-s2.0-0034899522 10.1128/JVI.75.16.7583-7591.2001 (Pubitemid 32738016)
102. Dyson N., Howley P. M., Munger K., Harlow E., The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989 243 4893 934 937 2-s2.0-0024535228 (Pubitemid 19066153)
103. Ofir M., Hacohen D., Ginsberg D., miR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Molecular Cancer Research 2011 9 4 440 447 2-s2.0-79954459249 10.1158/1541-7786.MCR-10-0344
104. Bueno M. J., De Cedrón M. G., Laresgoiti U., Fernández- Piqueras J., Zubiaga A. M., Malumbres M., Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling. Molecular and Cellular Biology 2010 30 12 2983 2995 2-s2.0-77953469799 10.1128/MCB.01372-09
105. da Silva Cardeal L. B., Boccardo E., Termini L., Rabachini T., Andreoli M. A., di Loreto C., Filho A. L., Villa L. L., Maria-Engler S. S., HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis. PLoS One 2012 7 3 2-s2.0-84858378580 10.1371/journal.pone.0033585 e33585
106. Takagi S., Simizu S., Osada H., Reck negatively regulates matrix metalloproteinase-9 transcription. Cancer Research 2009 69 4 1502 1508 2-s2.0-60649086817 10.1158/0008-5472.CAN-08-2635
107. Sasahara R. M., Brochado S. M., Takahashi C., Oh J., Maria-Engler S. S., Granjeiro J. M., Noda M., Sogayar M. C., Transcriptional control of the RECK metastasis/angiogenesis suppressor gene. Cancer Detection and Prevention 2002 26 6 435 443 2-s2.0-0036919274 10.1016/S0361-090X(02)00123-X (Pubitemid 36035373)
108. Yi R., Poy M. N., Stoffel M., Fuchs E., A skin microRNA promotes differentiation by repressing 'stemness'. Nature 2008 452 7184 225 229 2-s2.0-40749111551 10.1038/nature06642 (Pubitemid 351380241)
109. Melar-New M., Laimins L. A., Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. Journal of Virology 2010 84 10 5212 5221 2-s2.0-77951454817 10.1128/JVI.00078-10
110. Lena A. M., Shalom-Feuerstein R., di Val Cervo P. R., Aberdam D., Knight R. A., Melino G., Candi E., miR-203 represses "stemness" by repressing ΔNp63. Cell Death and Differentiation 2008 15 7 1187 1195 2-s2.0-45449097073 10.1038/cdd.2008.69 (Pubitemid 351850972)
111. Truong A. B., Kretz M., Ridky T. W., Kimmel R., Khavari P. A., p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes and Development 2006 20 22 3185 3197 2-s2.0-33751230475 10.1101/gad.1463206 (Pubitemid 44790632)
112. Spitkovsky D., Hehner S. P., Hofmann T. G., Möller A., Lienhard Schmitz M., The human papillomavirus oncoprotein E7 attenuates NF- B activation by targeting the I B kinase complex. Journal of Biological Chemistry 2002 277 28 25576 25582 2-s2.0-0037067782 10.1074/jbc.M201884200 (Pubitemid 34951874)
113. McKenna D. J., McDade S. S., Patel D., McCance D. J., MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6. Journal of Virology 2010 84 20 10644 10652 2-s2.0-77957195647 10.1128/JVI.00703-10
114. Ferretti E., De Smaele E., Po A., Marcotullio L. D., Tosi E., Espinola M. S. B., Rocco C. D., Riccardi R., Giangaspero F., Farcomeni A., Nofroni I., Laneve P., Gioia U., Caffarelli E., Bozzoni I., Screpanti I., Gulino A., MicroRNA profiling in human medulloblastoma. International Journal of Cancer 2009 124 3 568 577 2-s2.0-58149279841 10.1002/ijc.23948
115. Gaur A., Jewell D. A., Liang Y., Ridzon D., Moore J. H., Chen C., Ambros V. R., Israel M. A., Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Research 2007 67 6 2456 2468 2-s2.0-34047270440 10.1158/0008-5472.CAN-06-2698 (Pubitemid 46548930)
116. Katada T., Ishiguro H., Kuwabara Y., Kimura M., Mitul A., Mori Y., Ogawa R., Harata K., Fujii Y., MicroRNA expression profile in undifferentiated gastric cancer. International Journal of Oncology 2009 34 2 537 542 2-s2.0-64549124430 10.3892/ijo-00000179
117. Bandrés E., Cubedo E., Agirre X., Malumbres R., Zárate R., Ramirez N., Abajo A., Navarro A., Moreno I., Monzó M., García-Foncillas J., Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Molecular Cancer 2006 5, article 29 2-s2.0-33747628074 10.1186/1476-4598-5-29 (Pubitemid 44264064)
118. Kong W., Yang H., He L., Zhao J. J., Coppola D., Dalton W. S., Cheng J. Q., MicroRNA-155 is regulated by the transforming growth factor β /Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Molecular and Cellular Biology 2008 28 22 6773 6784 2-s2.0-55849123946 10.1128/MCB.00941-08
119. Perez-Moreno M., Jamora C., Fuchs E., Sticky business: orchestrating cellular signals at adherens junctions. Cell 2003 112 4 535 548 2-s2.0-0037459077 10.1016/S0092-8674(03)00108-9 (Pubitemid 36263085)
120. Peralta-Zaragoza O., Bermúdez-Morales V., Gutiérrez- Xicotencatl L., Alcocer-González J., Recillas-Targa F., Madrid-Marina V., E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor β 1 promoter throughout Sp1 recognition sequence. Viral Immunology 2006 19 3 468 480 2-s2.0-33750954562 10.1089/vim.2006.19.468 (Pubitemid 44735059)
121. Noordhuis M. G., Fehrmann R. S. N., Wisman G. B. A., Nijhuis E. R., Van Zanden J. J., Moerland P. D., Ver Loren Van Themaat E., Volders H. H., Kok M., Ten Hoor K. A., Hollema H., De Vries E. G. E., De Bock G. H., Van Der Zee A. G. J., Schuuring E., Involvement of the TGF- β and β -catenin pathways in pelvic lymph node metastasis in early-stage cervical cancer. Clinical Cancer Research 2011 17 6 1317 1330 2-s2.0-79952725039 10.1158/1078-0432.CCR-10-2320
122. Ahn W. S., Bae S. M., Lee J. M., Namkoong S. E., Han S. J., Cho Y. L., Nam G. H., Seo J. S., Kim C. K., Kim Y. W., Searching for pathogenic gene functions to cervical cancer. Gynecologic Oncology 2004 93 1 41 48 2-s2.0-12144286611 10.1016/j.ygyno.2003.11.031 (Pubitemid 38429547)
123. Iorio M. V., Ferracin M., Liu C. G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., Ménard S., Palazzo J. P., Rosenberg A., Musiani P., Volinia S., Nenci I., Calin G. A., Querzoli P., Negrini M., Croce C. M., MicroRNA gene expression deregulation in human breast cancer. Cancer Research 2005 65 16 7065 7070 2-s2.0-23844555119 10.1158/0008-5472.CAN-05-1783 (Pubitemid 41161233)
124. Maufort J. P., Shai A., Pitot H. C., Lambert P. F., A role for HPV16 E5 in cervical carcinogenesis. Cancer Research 2010 70 7 2924 2931 2-s2.0-77950833525 10.1158/0008-5472.CAN-09-3436
125. Kivi N., Greco D., Auvinen P., Auvinen E., Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression. Oncogene 2008 27 18 2532 2541 2-s2.0-42249098858 10.1038/sj.onc.1210916 (Pubitemid 351550881)
126. Riley R. R., Duensing S., Brake T., Münger K., Lambert P. F., Arbeit J. M., Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Research 2003 63 16 4862 4871 2-s2.0-0042440926 (Pubitemid 37022618)
127. Greco D., Kivi N., Qian K., Leivonen S.-K., Auvinen P., Auvinen E., Human papillomavirus 16 E5 modulates the expression of host microRNAS. PLoS One 2011 6 7 2-s2.0-79959783574 10.1371/journal.pone.0021646 e21646
128. Sabatini P. J. B., Zhang M., Silverman-Gavrila R., Bendeck M. P., Langille B. L., Homotypic and endothelial cell adhesions via N-cadherin determine polarity and regulate migration of vascular smooth muscle cells. Circulation Research 2008 103 4 405 412 2-s2.0-50949116343 10.1161/CIRCRESAHA. 108.175307
129. Mani S. A., Guo W., Liao M.-J., Eaton E. N., Ayyanan A., Zhou A. Y., Brooks M., Reinhard F., Zhang C. C., Shipitsin M., Campbell L. L., Polyak K., Brisken C., Yang J., Weinberg R. A., The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008 133 4 704 715 2-s2.0-43049165453 10.1016/j.cell.2008.03.027 (Pubitemid 351636299)
130. Pim D., Bergant M., Boon S. S., Ganti K., Kranjec C., Massimi P., Subbaiah V. K., Thomas M., Tomaic V., Banks L., Human papillomaviruses and the specificity of PDZ domain targeting. The FEBS Journal 2012 279 19 3530 3537 10.1111/j.1742-4658.2012.08709
131. Gantier M. P., McCoy C. E., Rusinova I., Saulep D., Wang D., Xu D., Irving A. T., Behlke M. A., Hertzog P. J., MacKay F., Williams B. R. G., Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Research 2011 39 13 5692 5703 2-s2.0-80052213072 10.1093/nar/gkr148
132. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., Li Q., Li X., Wang W., Zhang Y., Wang J., Jiang X., Xiang Y., Xu C., Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Wang J., Zen K., Zhang J., Zhang C. Y., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research 2008 18 10 997 1006 2-s2.0-53349177819 10.1038/cr.2008.282
133. Li J., Smyth P., Flavin R., Cahill S., Denning K., Aherne S., Guenther S. M., O'Leary J. J., Sheils O., Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnology 2007 7, article 36 2-s2.0-34447506198 10.1186/1472-6750-7-36 (Pubitemid 47065165)
134. Lee J.-W., Choi C. H., Choi J. J., Park Y. A., Kim S. J., Hwang S. Y., Kim W. Y., Kim T. J., Lee J. H., Kim B. G., Bae D. S., Altered microRNA expression in cervical carcinomas. Clinical Cancer Research 2008 14 9 2535 2542 2-s2.0-52049097315 10.1158/1078-0432.CCR-07-1231
135. Calin G. A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S. E., Iorio M. V., Visone R., Sever N. I., Fabbri M., Iuliano R., Palumbo T., Pichiorri F., Roldo C., Garzon R., Sevignani C., Rassenti L., Alder H., Volinia S., Liu C.-G., Kipps T. J., Negrini M., Croce C. M., A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. The New England Journal of Medicine 2005 353 17 1793 1801 2-s2.0-27244434788 10.1056/NEJMoa050995 (Pubitemid 41549891)
136. Roldo C., Missiaglia E., Hagan J. P., Falconi M., Capelli P., Bersani S., Calin G. A., Volinia S., Liu C.-G., Scarpa A., Croce C. M., MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. Journal of Clinical Oncology 2006 24 29 4677 4684 2-s2.0-33750600178 10.1200/JCO.2005.05.5194 (Pubitemid 46630931)
137. Blenkiron C., Goldstein L. D., Thorne N. P., Spiteri I., Chin S. F., Dunning M. J., Barbosa-Morais N. L., Teschendorff A. E., Green A. R., Ellis I. O., Tavaré S., Caldas C., Miska E. A., MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biology 2007 8 10, article R214 2-s2.0-37549024511 10.1186/gb-2007-8-10-r214 (Pubitemid 351917463)
138. Raponi M., Dossey L., Jatkoe T., Wu X., Chen G., Fan H., Beer D. G., MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Research 2009 69 14 5776 5783 2-s2.0-67651002796 10.1158/0008-5472.CAN- 09-0587
139. Hu X., Schwarz J. K., Lewis J. S. Jr., Huettner P. C., Rader J. S., Deasy J. O., Grigsby P. W., Wang X., A microRNA expression signature for cervical cancer prognosis. Cancer Research 2010 70 4 1441 1448 2-s2.0-76749142479 10.1158/0008-5472.CAN-09-3289
140. Heiden M. G. V., Cantley L. C., Thompson C. B., Understanding the warburg effect: the metabolic requirements of cell proliferation. Science 2009 324 5930 1029 1033 2-s2.0-66249108601 10.1126/science.1160809
141. Gee H. E., Camps C., Buffa F. M., Patiar S., Winter S. C., Betts G., Homer J., Corbridge R., Cox G., West C. M. L., Ragoussis J., Harris A. L., hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 2010 116 9 2148 2158 2-s2.0-77951463320 10.1002/cncr.25009